Medikaloka Hermina Tbk PT
IDX:HEAL

Watchlist Manager
Medikaloka Hermina Tbk PT Logo
Medikaloka Hermina Tbk PT
IDX:HEAL
Watchlist
Price: 1 055 IDR 0.96% Market Closed
Market Cap: 16.2T IDR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+66%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

HEAL Price Targets Summary
Medikaloka Hermina Tbk PT

Wall Street analysts forecast HEAL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HEAL is 1 701.7 IDR with a low forecast of 1 343.3 IDR and a high forecast of 2 079 IDR.

HEAL Lowest Forecast
Wall Street Target
1 343.3 IDR
27% Upside
HEAL Average Forecast
Wall Street Target
1 701.7 IDR
61% Upside
HEAL Highest Forecast
Wall Street Target
2 079 IDR
97% Upside
Lowest
Price Target
1 343.3 IDR
27% Upside
Average
Price Target
1 701.7 IDR
61% Upside
Highest
Price Target
2 079 IDR
97% Upside
Medikaloka Hermina Tbk PT Competitors:
Price Targets
A
AEVS
Aevis Victoria SA
13% Upside
JYNT
Joint Corp
59% Upside
HCG
Healthcare Global Enterprises Ltd
2% Upside
F
FORTIS
Fortis Healthcare Ltd
14% Upside
A
AEVS
Aevis Victoria SA
13% Upside
JYNT
Joint Corp
59% Upside
HCG
Healthcare Global Enterprises Ltd
2% Upside
F
FORTIS
Fortis Healthcare Ltd
14% Upside
SILO
Siloam International Hospitals Tbk PT
41% Upside
APOLLOHOSP
Apollo Hospitals Enterprise Ltd
14% Upside
INDRAMEDCO
Indraprastha Medical Corporation Ltd
70% Upside
A
4007
Al Hammadi Holding Co
11% Upside

Revenue
Forecast

Revenue Estimate
Medikaloka Hermina Tbk PT

For the last 8 years the compound annual growth rate for Medikaloka Hermina Tbk PT's revenue is 15%. The projected CAGR for the next 3 years is 13%.

15%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medikaloka Hermina Tbk PT

For the last 8 years the compound annual growth rate for Medikaloka Hermina Tbk PT's operating income is 16%. The projected CAGR for the next 2 years is 16%.

16%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medikaloka Hermina Tbk PT

For the last 8 years the compound annual growth rate for Medikaloka Hermina Tbk PT's net income is 31%. The projected CAGR for the next 3 years is 20%.

31%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
HEAL intrinsic value, competitors valuation, and company profile.
DCF Valuation
HEAL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HEAL stock valuation using valuation multiples.
Wall Street Estimates
HEAL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HEAL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HEAL's stock price target?
Price Target
1 701.7 IDR

According to Wall Street analysts, the average 1-year price target for HEAL is 1 701.7 IDR with a low forecast of 1 343.3 IDR and a high forecast of 2 079 IDR.

What is Medikaloka Hermina Tbk PT's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Medikaloka Hermina Tbk PT's revenue is 15%. The projected CAGR for the next 3 years is 13%.

What is Medikaloka Hermina Tbk PT's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Medikaloka Hermina Tbk PT's operating income is 16%. The projected CAGR for the next 2 years is 16%.

What is Medikaloka Hermina Tbk PT's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Medikaloka Hermina Tbk PT's net income is 31%. The projected CAGR for the next 3 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 248,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.